Top videos
Video is an excellent introduction to Hysterosalpingography and summarizes different pathologies. While the information on this presentation is about health care issues, it is not medical advice. People seeking specific medical advice or assistance should contact their personal physician. Although we believe the information in this presentation to be accurate and timely, because of the rapid advances in health care and our reliance on information provided by outside sources, we make no warranty or guarantee concerning the accuracy or reliability of the content or other material which we may reference. When clinical matters are discussed, the opinions presented are those of the discussants only. The material discussed on the presentation is not intended to present the only or necessarily the best method or procedure, but rather presents the approach or opinion of the discussant. This presentation is provided in an “as is” format without warranties of any kind, expressed or implied, including but not limited to warranties of title, non-infringement or implied warranties of merchantability or fitness for a particular purpose.
Source ABC7, 24 November 2009 An initial single-arm Phase II trial (ACT II) has reported promising preliminary data in 23 patients who received CDX-110 vaccine. Median time to disease progression was 16.6 months and estimated median overall survival was 33.1 months. This compared favorably with data for a historical control group in which median time to progression was 6.4 months and median overall survival was 15.2 months. The study was sponsored by Celldex Therapeutics Inc. of Phillipsburg, NJ
Learn about electromagnetic navigation diagnostic bronchoscopy, a new technology used to diagnose small lung cancer tumors as small as a pencil eraser before they have the chance to spread. Cleveland Clinic physician Dr. Thomas Gildea demonstrates how this endobronchial ultrasound procedure, which involves using a small camera probe inserted thru the nose into the lungs, allows doctors to reach possible cancer in the lungs that they could never reliably get to before